Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 11/20 | 0.64 |
| ▸ | LPAR2 | Q9HBW0 | 7/20 | 0.64 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | CDC25A | P30304 | 1/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.50 |
| ▸ | AKT1 | P31749 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4451412 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL27845159 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL4453696 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL4446489 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL27845162 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL28118087 | 0.97 | LPAR3 (0.60) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL585443 | 0.90 | — | — | |
| SCHEMBL27396825 | 0.89 | LPAR3 (0.64) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL8041879 | 0.89 | LPAR3 (0.48) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL5491386 | 0.87 | CYP3A4 (0.46) | LPAR3LPAR2LPAR1CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3894441-A1 | RANK ANTAGONISTS AND USES THEREFOR | The Council of the Queensland Institute of Medical Research (AU) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020113274-A1 | RANK ANTAGONISTS AND USES THEREFOR | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2020-06-11 | — | — | WO | disclosed |
| CN-108291157-A | Selective hydrogenation using flow index | 切弗朗菲利浦化学公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-107667092-A | Formylated N Hete rocyclic derivatives as FGFR4 inhibitor | 诺华股份有限公司 | 2018-02-06 | — | — | CN | disclosed |
| CN-107107049-A | Selective hydrogenation catalyst and its preparation and application | 切弗朗菲利浦化学公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-102341175-B | Selective hydrogenation catalyst and preparation and application thereof | Chevron Phillips Chemical Co.,L.P. (US) | 2016-11-30 | — | — | CN | disclosed |
| CN-102341175-A | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |